Voxsanity

Who may be able to join

Who might be able to join this trial:

You took part in a previous related clinical trial (called study C87037 or NCT00291668) and your Crohn's disease symptoms improved during that study.

Who may not be able to join:

You took part in the previous related clinical trial (study C87037 or NCT00291668) but your Crohn's disease got worse during that study and you needed to change your treatment as a result.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Trial details

Status

Completed

Phase

Phase 2

Sponsor

UCB Japan Co. Ltd.

Registry

clinicaltrials_gov

Start date

1 May 2006

Est. completion

1 April 2008

Where this trial is recruiting

🇯🇵 Japan

Primary endpoints

Percentage of Crohn's Disease Activity Index (CDAI) Responders at Week 26

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov